IIT Relivion
Prospective observational study of 3 month response to external combined occipital and trigeminal neurostimulation (eCOT-NS).
The purpose of this study is to compare the responses and treatment adherence of the standard of care use of the FDA approved external combined occipital and trigeminal neurostimulation (eCOT-NS) device also called Relivion.
Contact Us
Enrollment Information
Contact Rachel Stancl at (602) 406-6236 or email DH-MigraineResearch@DignityHealth.org